Chile has become the latest country to approve Chinese firm Sinovac Biotech’s coronavirus vaccine, which has been subject to close scrutiny over its efficacy data.The Chilean Public Health Institute granted authorisation on Wednesday, saying CoronaVac, as the product is known, was safe for all age groups. A final stage clinical trial conducted by Pontifical Catholic University of Chile showed the vaccine was effective in “blocking the coronavirus from reproducing”, the institute said.“CoronaVac…

This post was originally published on South China Morning Post.